Does ALEMTUZUMAB Cause Bronchospasm? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Bronchospasm have been filed in association with ALEMTUZUMAB (Campath). This represents 0.1% of all adverse event reports for ALEMTUZUMAB.
19
Reports of Bronchospasm with ALEMTUZUMAB
0.1%
of all ALEMTUZUMAB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Bronchospasm From ALEMTUZUMAB?
Of the 19 reports, 2 (10.5%) resulted in death, 5 (26.3%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Bronchospasm Listed in the Official Label?
Yes, Bronchospasm is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Bronchospasm?
ALBUTEROL (431)
OXALIPLATIN (422)
OMALIZUMAB (370)
PROPOFOL (356)
PACLITAXEL (333)
ROCURONIUM (252)
MEPOLIZUMAB (249)
IBUPROFEN (203)
ACETAMINOPHEN (195)
CARBOPLATIN (188)
Which ALEMTUZUMAB Alternatives Have Lower Bronchospasm Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET